CD163 and COVID-19: The severe cases of COVID-19 were associated with the appearance of monocytes expressing a low level of cell-surface HLA-DR and possessing an anti-inflammatory profile, which manifested in the active expression of genes encoding the MAFB transcription factor, PLBD1 (phospholipase B domain containing 1) and CD163 [48].